OtherChemotherapy, Antibiotics, and Gene Therapy
XRCC3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase check point activation, and reduced apoptosis
Zhiyuan Xu, Martin Loignon, Feiyu Han, Lawrence C. Panasci and Raquel Aloyz
Journal of Pharmacology and Experimental Therapeutics April 20, 2005, DOI: https://doi.org/10.1124/jpet.105.084053
Zhiyuan Xu
Martin Loignon
Feiyu Han
Lawrence C. Panasci
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherChemotherapy, Antibiotics, and Gene Therapy
XRCC3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase check point activation, and reduced apoptosis
Zhiyuan Xu, Martin Loignon, Feiyu Han, Lawrence C. Panasci and Raquel Aloyz
Journal of Pharmacology and Experimental Therapeutics April 20, 2005, DOI: https://doi.org/10.1124/jpet.105.084053
OtherChemotherapy, Antibiotics, and Gene Therapy
XRCC3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase check point activation, and reduced apoptosis
Zhiyuan Xu, Martin Loignon, Feiyu Han, Lawrence C. Panasci and Raquel Aloyz
Journal of Pharmacology and Experimental Therapeutics April 20, 2005, DOI: https://doi.org/10.1124/jpet.105.084053
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement